Global RNA Sequencing Market - Forecasts from 2017 to 2022
The global RNA sequencing (RNA-Seq) market is projected to witness a significant growth rate during the forecast period, growing at a CAGR of 12.07% during the forecast period to reach a total market size of US$3.692 billion by 2022, increasing from US$1.863 billion in 2016. Viral evolution and increasing incidence of genetic disorders have elevated the need for technical advancements in RNA sequencing products which are expected to drive the market over the projected period. Increasing grants for RNA sequencing have led to increasing number of research activities involving RNA sequencing. However, lack of skilled professionals required for RNA sequencing will impede the market growth. Moreover, strict government regulations in some regions will further slow down the growth rate of the market.
Research Methodology
The report provides a brief introduction of the market and deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segments which have been covered as part of the report.
Market Dynamics
The next section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides global and regional regulations which are determining the market growth and industry value chain analysis of the global RNA sequencing market. Complete industry analysis has also been covered through Porter’s five forces model as a part of this report section.
Competitive Insight
The major players discussed in this report include Illumina, Inc., Macrogen Inc., GATC Biotech AG., Eurofins Scientific, PerkinElmer Inc., and Oxford Nanopore Technologies among few others.
Segmentation
In the report, global RNA sequencing market has been segmented by technology, applications, end-user, and geography:
By Technology
Ion Semiconductor Sequencing
Single-Molecule Real-Time (SMRT) Sequencing
Nanopore Sequencing
Sequencing By Synthesis (SBS)
By Applications
Small RNA Sequencing
Expression Profiling Analysis
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research Centers
Biotechnology Labs
Healthcare Centers
Others
By Geography
North America
South America
Europe
Middle East and Africa (MEA)
Asia Pacific (APAC)
Research Methodology
The report provides a brief introduction of the market and deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segments which have been covered as part of the report.
Market Dynamics
The next section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides global and regional regulations which are determining the market growth and industry value chain analysis of the global RNA sequencing market. Complete industry analysis has also been covered through Porter’s five forces model as a part of this report section.
Competitive Insight
The major players discussed in this report include Illumina, Inc., Macrogen Inc., GATC Biotech AG., Eurofins Scientific, PerkinElmer Inc., and Oxford Nanopore Technologies among few others.
Segmentation
In the report, global RNA sequencing market has been segmented by technology, applications, end-user, and geography:
By Technology
Ion Semiconductor Sequencing
Single-Molecule Real-Time (SMRT) Sequencing
Nanopore Sequencing
Sequencing By Synthesis (SBS)
By Applications
Small RNA Sequencing
Expression Profiling Analysis
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research Centers
Biotechnology Labs
Healthcare Centers
Others
By Geography
North America
South America
Europe
Middle East and Africa (MEA)
Asia Pacific (APAC)
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
5. GLOBAL RNA SEQUENCING MARKET FORECAST BY TECHNOLOGY (US$ BILLION)
5.1. Introduction
5.2. Ion Semiconductor Sequencing
5.3. Single-Molecule Real-Time (SMRT) Sequencing
5.4. Nanopore Sequencing
5.5. Sequencing By Synthesis (SBS)
6. GLOBAL RNA SEQUENCING MARKET FORECAST BY APPLICATION (US$ BILLION)
6.1. Introduction
6.2. Small RNA Sequencing
6.3. Expression Profiling Analysis
6.4. De Novo Transcriptome Assembly
6.5. Variant Calling and Transcriptome Epigenetics
7. GLOBAL RNA SEQUENCING MARKET FORECAST BY END-USER (US$ BILLION)
7.1. Introduction
7.2. Research Centers
7.3. Biotechnology Labs
7.4. Healthcare Centers
7.5. Others
8. GLOBAL RNA SEQUENCING MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
8.1. Introduction
8.2. North America
8.3. South America
8.4. Europe
8.5. Middle East and Africa (MEA)
8.6. Asia Pacific (APAC)
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Illumina, Inc.
10.1.1. Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Key Developments
10.2. Macrogen Inc.
10.2.1. Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Key Developments
10.3. GATC Biotech AG.
10.3.1. Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Key Developments
10.4. Eurofins Scientific
10.4.1. Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Key Developments
10.5. PerkinElmer Inc.
10.5.1. Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Key Developments
10.6. Oxford Nanopore Technologies
10.6.1. Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Key Developments
10.7. BGI (Beijing Genomics Institute)
10.7.1. Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Key Developments
10.8. Pacific Biosciences of California, Inc.
10.8.1. Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Key Developments
List of Tables
List of Figures
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
5. GLOBAL RNA SEQUENCING MARKET FORECAST BY TECHNOLOGY (US$ BILLION)
5.1. Introduction
5.2. Ion Semiconductor Sequencing
5.3. Single-Molecule Real-Time (SMRT) Sequencing
5.4. Nanopore Sequencing
5.5. Sequencing By Synthesis (SBS)
6. GLOBAL RNA SEQUENCING MARKET FORECAST BY APPLICATION (US$ BILLION)
6.1. Introduction
6.2. Small RNA Sequencing
6.3. Expression Profiling Analysis
6.4. De Novo Transcriptome Assembly
6.5. Variant Calling and Transcriptome Epigenetics
7. GLOBAL RNA SEQUENCING MARKET FORECAST BY END-USER (US$ BILLION)
7.1. Introduction
7.2. Research Centers
7.3. Biotechnology Labs
7.4. Healthcare Centers
7.5. Others
8. GLOBAL RNA SEQUENCING MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
8.1. Introduction
8.2. North America
8.3. South America
8.4. Europe
8.5. Middle East and Africa (MEA)
8.6. Asia Pacific (APAC)
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Illumina, Inc.
10.1.1. Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Key Developments
10.2. Macrogen Inc.
10.2.1. Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Key Developments
10.3. GATC Biotech AG.
10.3.1. Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Key Developments
10.4. Eurofins Scientific
10.4.1. Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Key Developments
10.5. PerkinElmer Inc.
10.5.1. Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Key Developments
10.6. Oxford Nanopore Technologies
10.6.1. Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Key Developments
10.7. BGI (Beijing Genomics Institute)
10.7.1. Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Key Developments
10.8. Pacific Biosciences of California, Inc.
10.8.1. Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Key Developments
List of Tables
List of Figures
